NeuVax Phase 3 trial entering key moments. If interim results are reported (70 events) in Nov. - Dec. NeuVax < 20% reduction in DFS, after March NeuVax > 30% reduction in DFS. Bashers don't have much longer to bash! I expect a run-up will start in Jan. or Feb. if interim data has not been announced by then.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.